John McGiven of the Animal Health Veterinary Laboratories Agency in the United Kingdom, along with David Bundle of the University of Alberta in Canada, will evaluate a glycoconjugate vaccine for brucellosis that is safe, stable, inexpensive, and efficacious. Complementary diagnostics will allow for the differentiation of vaccinated and infected subjects and assist in the control of this insidious zoonotic disease. They will test both the vaccine and the diagnostic in a standardized mouse model.
Grant ID
OPP1096883
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Challenge
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False